首页> 外文期刊>BMC Cancer >Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus
【24h】

Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus

机译:肾静脉肿瘤血栓局部晚期肾细胞癌的长期存活和预后因素

获取原文
           

摘要

Previous related studies have mainly focused on renal cell carcinoma (RCC) with venous tumor thrombus, specifically inferior vena cava tumor thrombus with renal vein tumor thrombus (RVTT). However, only a few studies have focused on postoperative long-term survival of RCC patients exclusively with RVTT. Our aim was to investigate the independent prognostic factors for locally advanced RCC with RVTT in China. Patients with locally advanced RCC with RVTT were enrolled for the study from January 2000 to December 2015. All patients underwent radical nephrectomy. Survival analysis was estimated using Kaplan-Meier. Univariable and multivariable survival analyses were performed using COX. Patients were divided into high-risk, middle-risk, and low-risk groups based on independent prognostic factors and then analyzed for survival. One hundred twenty-eight consecutive patients (103 men & 25 women) were enrolled with a median age of 61?years. Thrombi were all graded 0 using the Mayo system, of which 23 were friable. None of the thrombi detached during surgery. 121 patients were successfully followed up, with a median follow-up period of 47?months. Median overall survival was 127?months (95%CI: 101-153). The 5-year and 10-year cancer-specific survival (CSS) rate was 67.9 and 57.0%. 59 patients had recurrence with median time of 40?months. Friable thrombus, paraneoplastic syndrome (PNS), modified Fuhrman grade 3/4 and perirenal fat invasion were independent prognostic factors (p??0.05). The 5-year CSS for the Low-risk group (no factors) was 100%, Middle-risk group (1-2 factors) was 68.6%, while the High-risk group (3-4 factors) was 0%. After radical surgery, RCC patients with RVTT had a relatively fair prognosis except for patients with friable thrombus, PNS, higher modified Fuhrman grade and perirenal fat invasion.
机译:之前的相关研究主要集中在静脉肿瘤血栓肾细胞癌(RCC)上,特别是肾静脉肿瘤血栓(RVTT)的特异性下腔静脉肿瘤血栓。然而,只有少数研究专注于RVTT专门的RCC患者的术后长期存活。我们的目标是调查中国局部高级RCC的独立预后因素。患有RVTT局部高级RCC的患者于2000年1月至2015年12月注册了该研究。所有患者都接受了自由基肾切除术。使用Kaplan-Meier估计存活分析。使用COX进行功能衰弱和多变量的存活分析。患者基于独立预后因素分为高风险,中等风险和低风险群体,然后分析生存。连续一百二十八名患者(103名男子和25名女性)注册了61岁的年龄为61岁。血栓全部使用蛋黄酱系统进行分级0,其中23是易碎的。在手术期间没有血栓脱落。 121名患者成功跟进,中位随访时间为47个月。中位数总生存率为127?月(95%CI:101-153)。 5年和10年的癌症特异性生存率(CSS)率为67.9和57.0%。 59名患者复发,中位时间为40?月。易碎的血栓,平原综合征(PNS),改性Fuhrman级3/4和脑脂肪侵袭是独立的预后因子(P?<?0.05)。低风险组(无因素)为5%的CSS为100%,中风险组(1-2个因素)为68.6%,而高风险组(3-4个因素)为0%。自由基手术后,RCC患者的RVTT患者具有相对公平的预后,除了令人易碎的血栓,PNS,更高改良的FUHRMAN等级和脑脂肪侵袭的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号